Innovative medical devices that are so-called new examination and treatment method (NUB) according to § 137e SGB V and which have shown to be a potential required treatment alternative need to be tested within the framework of a testing guideline of the Federal Joint Committee (G-BA). Aim is to evaluate the medical benefit. In yesterday's press release, the G-BA publicly announced our next steps which will be submission of our study concept to the Federal Ministry of Health and to obtain the positive vote of the Ethics Committee. As independent scientific institution (UWI), we look forward to making our contribution to improve patient care and support companies to get their innovative products reimbursed in Germany.